JR
Jean-Loup Romet-Lemonne
Chief Executive OfficerDirector
Jean-Loup Romet-LemonneChief Executive OfficerDirector
Jean-Loup Romet-Lemonne insider trades: Idm Pharma (IDMI) SEC Form 4 filings
Chief Executive Officer, Idm Pharma 3 Form 4 filings
3
Form 4 filings
last Apr 11, 2007
3
Grants and awards
filings
1
Company
Companies
Where Jean-Loup reports to the SEC
About Jean-Loup Romet-Lemonne's insider trades
Jean-Loup Romet-Lemonne is Chief Executive Officer at Idm Pharma (IDMI). Jean-Loup has not reported an open-market purchase or sale.
Their filings also include grants and awards (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every IDMI insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.